STERIS (STE) Revenue — Quarter Ended Sep 30, 2023
Revenue for the quarter declined compared to the same period last year, but increased sequentially from the immediately preceding quarter. The directional shift reflects a reversal from the prior quarter's growth rate.
Key takeaway
Quarter ended Sep 30, 2023 · FY2024 Q2
Revenue for the quarter declined compared to the same period last year, but increased sequentially from the immediately preceding quarter. The directional shift reflects a reversal from the prior quarter's growth rate.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.2B
Revenue reported for this quarter.
Quarter-over-quarter
+4.6%
Change from the immediately preceding quarter.
Year-over-year
-5.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $1.2B | +0.6% |
| Mar 31, 2023 | $1.3B | +5.8% |
| Jun 30, 2023 | $1.2B | +12.5% |
| Sep 30, 2023 | $1.2B | -5.1% |
Revenue performance
The reported revenue decreased year-over-year, marking a downturn from the same quarter a year earlier, though it rose relative to the prior quarter.
Quarterly comparison
Compared with the immediately preceding quarter, revenue increased; compared with the same quarter one year earlier, revenue decreased. This pattern contrasts with the preceding quarter's year-over-year growth.
What to watch
Management commentary highlights continued inventory investment to reduce lead times and meet customer demand, which may affect future working capital.